CSI Market
Sign In | Register

Bionano Genomics Inc (BNGO) Annual Balance Sheets

Annual · GAAP · USD millions
Access BNGO quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Bionano Genomics Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.99
Restricted Cash and Investments, Current, Total10.27
Available-for-sale Securities, Debt Securities, Current MA16.28
Cash & Short-term Investments28.00
Accounts receivable5.20
Other Receivables0.00
Notes Receivable, Current0.00
Inventories0.00
Other Current Assets5.45
Prepaid Expense And Other Assets Current5.20
Total Current Assets45.39
Equipment/Property/Plant Net14.85
Goodwill net0.00
Intangible Assets4.35
Long-term investments0.00
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent9.01
Inventory Current5.45
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset3.22
Finance Lease Right Of Use Asset3.10
Total Assets73.58
Liabilities
Accounts Payable, Current AC5.59
Accrued Liabilities, Current AC5.46
Other Liabilities, Current11.89
Taxes Payable0.00
Deferred Revenue, Current DE0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities22.94
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent6.22
Operating Lease Liability Current0.70
Finance Lease Liability Current0.25
Operating Lease Liability Noncurrent2.49
Finance Lease Liability Noncurrent3.48
Contingent Consideration Fair Value Of Contingent Liability-
Contract With Customer Liability Noncurrent0.25
Total Liabilities29.16
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock764.03
Retained Earnings / Accumulated Deficit-719.62
Accumulated Other Comprehensive Income0.00
Other Equity0.02
Common Stockholder's Equity44.42
Total Stockholder's Equity44.42
Liabilities & Stockholder's Equity73.58
4 historic quarters locked

Sign in to unlock the full Bionano Genomics Inc balance sheet history.

Sign In Create Free Account

About Bionano Genomics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001411690-26-000007

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License